Perspectives on psychedelic treatment and research in eating disorders: a web-based questionnaire study of people with eating disorders.


Journal

Journal of integrative neuroscience
ISSN: 0219-6352
Titre abrégé: J Integr Neurosci
Pays: Singapore
ID NLM: 101156357

Informations de publication

Date de publication:
30 Sep 2021
Historique:
received: 22 02 2021
revised: 09 03 2021
accepted: 19 04 2021
entrez: 14 10 2021
pubmed: 15 10 2021
medline: 1 2 2022
Statut: ppublish

Résumé

Approximately 1.25 million people in the UK suffer from an eating disorder, yet the treatment options show limited efficacy, warranting the need for novel approaches. This study aimed to investigate the perspectives of people with eating disorders on the use of complementary therapies and psychedelic research and treatment. Two hundred participants with eating disorders took part in this web survey study. The majority of participants (70%) had used a complementary treatment to manage their eating disorder. Participants believed that psychedelic research was worthwhile in the context of a moderate level of concern. The most popular solutions to meet these concerns included providing education around psychedelics and their effects and use in psychiatry and experiencing endorsement from professionals in the area. Moreover, participant responses emphasized the need for a safe, monitored environment and the patient-therapist rapport in the context of psychedelic treatment. The findings are explored concerning future trials of psychedelics as a treatment for eating disorders.

Identifiants

pubmed: 34645088
pii: 1632962191325-1116268835
doi: 10.31083/j.jin2003059
doi:

Substances chimiques

Hallucinogens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

551-560

Informations de copyright

© 2021 The Author(s). Published by IMR Press.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Fiona Harding (F)

South London and Maudsley NHS Foundation Trust, SE5 8AZ London, UK.

Mathieu Seynaeve (M)

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College, SE5 8AZ London, UK.

Johanna Keeler (J)

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College, SE5 8AZ London, UK.

Hubertus Himmerich (H)

South London and Maudsley NHS Foundation Trust, SE5 8AZ London, UK.
Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College, SE5 8AZ London, UK.

Janet Treasure (J)

South London and Maudsley NHS Foundation Trust, SE5 8AZ London, UK.
Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College, SE5 8AZ London, UK.

Carol Kan (C)

Community Mental Health Team, St Ann's Hospital, N15 3TH London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH